Susquehanna International Group, LLP Liminal Bio Sciences Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021
BUY
$2.15 - $3.92 $4,730 - $8,624
2,200 Added 16.54%
15,500 $35,000
Q2 2021

Aug 11, 2021
BUY
$3.75 - $5.17 $49,875 - $68,761
13,300 New
13,300 $52,000

Others Institutions Holding LMNL

# of Institutions
2
Shares Held
234
Call Options Held
0
Put Options Held
0
View Full List

About Liminal BioSciences Inc.

LMNL Quotes by TradingView
  • Ticker LMNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,042,600
  • Description
  • Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...
More about LMNL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email